Janux Therapeutics, Inc.

JANX · Nasdaq · SIC 2834: Pharmaceutical Preparations
76
SEC Filings

Business Summary

PART I . Unless the context otherwise requires, the terms Janux Therapeutics, Janux, we, us, our and similar references in this Annual Report on Form 10-K refer to Janux Therapeutics, Inc. Overview We are an innovative clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying our proprietary technologies to our Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. ...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionJANXdiscussed_in_filing Cybersecurity
topic_mentionJANXdiscussed_in_filing Cybersecurity
topic_mentionJANXdiscussed_in_filing Healthcare & Bio
topic_mentionJANXdiscussed_in_filing Platform & Ecosystem
topic_mentionJANXdiscussed_in_filing Healthcare & Bio
topic_mentionJANXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076918EDGAR103K words
2025-02-272024-12-310000950170-25-029177EDGAR—
2024-03-082023-12-310000950170-24-028659EDGAR—
2023-03-102022-12-310000950170-23-007311EDGAR—
2022-03-182021-12-310000950170-22-004171EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269799EDGAR67K words
2025-08-072025-06-300000950170-25-105069EDGAR—
2025-05-082025-03-310000950170-25-067083EDGAR—
2024-11-062024-09-300000950170-24-122370EDGAR—
2024-08-072024-06-300000950170-24-092857EDGAR—
2024-05-082024-03-310000950170-24-054966EDGAR—
2023-11-072023-09-300000950170-23-060288EDGAR—
2023-08-082023-06-300000950170-23-039898EDGAR—
2023-05-092023-03-310000950170-23-019689EDGAR—
2022-11-102022-09-300000950170-22-024511EDGAR—
2022-08-092022-06-300000950170-22-016082EDGAR—
2022-05-102022-03-310000950170-22-008984EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076627EDGAR2K words
2026-01-220001193125-26-019520EDGAR—
2025-11-060001193125-25-269518EDGAR—
2025-09-190001193125-25-209259EDGAR—
2025-08-070000950170-25-105010EDGAR—
2025-06-130000950170-25-086284EDGAR—
2025-05-080000950170-25-066969EDGAR—
2025-02-270000950170-25-029165EDGAR—
2024-12-050001193125-24-271578EDGAR—
2024-12-020000950170-24-132302EDGAR—

76 total filings indexed. 49 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001817713
TickerJANX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 690f152090770503f1ed73f8aebd12f54ae5147c119dba57f6e577516952103c
parent: 51ce850503be30208105f059102e6695fa813cff4a1f7a4d484c236c4280d6c9
content hash: aa70dc7fcabd42476eed1b0f7eb9023dd83050b4a7da5dc8473165e1da2f07f8
signed: 2026-04-13T04:45:47.510Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf